We established an experimental system for measuring blood flow in the rat fundus and examined whether intravenously administered vasodilatory prostaglandins (PGE 1 , PGE 2 , and PGI 2 ), 8-(4-chlorophenylthio)-cAMP (a cAMP analogue), and nicardipine (a Ca 2+ -channel blocker) increase fundus blood flow (FBF). Under artificial ventilation, rats were injected with tetrodotoxin (50 µg / kg, i.v.) to eliminate any nerve activity and prevent movement of the eye.
Introduction
Because circulation in the fundus plays an important role in the pathogenesis of diabetic retinopathy (1, 2) and glaucoma (3, 4) , retinal and choroidal blood flow has been clinically assessed using laser-Doppler and laser-speckle techniques and so on. To develop novel therapeutics and strategies for improving ocular circulation, much information on retinal / choroidal blood flow obtained from in vivo experimentation using animal models with / without ocular diseases is needed. However, most research in the field of ocular circulation has been conducted using larger animals such as cows, piglets, rabbits, and cats, which due to their size, can be easily handled. Therefore, there is an extreme lack of information on the drug effects on retinal / choroidal circulation under pathological conditions. Because small animals such as rats and mice provide many pathological models, to better understand the regulatory mechanisms of ocular blood flow, we have developed an experimental system for measuring the fundus blood flow (FBF) of the rat.
Nitric oxide (NO) and prostaglandins (PGs) are thought to play an important role in the regulation of vascular tone. Indeed, inhibition of NO synthase and cyclooxygenase affected changes in retinal / choroidal blood flow in response to increases in perfusion pressure (5 -8) . These results suggest that both NO and PGs appear to be important in the regulatory mechanisms of retinal / choroidal hemodynamics. However, the vasorelaxant effects of NO on retinal / choroidal vasculature may be explained by PGI 2 released from endothelial cells (9, 10) . In preliminary studies, we also found that, NO-mediated vasodilation of retinal arterioles was largely attenuated by indomethacin, an inhibitor of cyclooxygenase, in rats (11, 12) . Therefore, we sought to focus on the effects of vasodilatory PGs including PGI 2 on FBF.
Among the PGs, PGE 1 , PGE 2 , and PGI 2 generally relax the blood vessels and act as vasodilators in the vasculatures of many organs (13 -16) . However, in the ocular vasculature, PGI 2 consistently produced the vasodilator responses (17 -23) , but the effects of PGE 1 and PGE 2 have been inconsistent across studies (18, 20, 23 -30) . The inconsistency might be due to species variations and different experimental preparations. Therefore, in the present study, we addressed the question of whether PGE 1 , PGE 2 , and PGI 2 increase FBF in rats using two non-invasive types of laser-Doppler flowmeters: the laser-Doppler flowmeter (FLO-N1) and the laser-Doppler color imager (MoorLDI-HR). Vasodilatory PGs could relax vascular smooth muscle through elevation of intracellular cAMP (16, 31) ; therefore, we also examined the effect of 8-(4chlorophenylthio)-cAMP (8-cpt-cAMP), a cAMP analogue, on FBF. The effects of vasodilatory PGs and the cAMP analogue on FBF and blood pressure were compared with those of nicardipine, a Ca 2+ -channel blocker. To measure FBF consistently by preventing movement of the eye, rats were treated with tetrodotoxin (TTX) under artificial ventilation. Because TTX decreased blood pressure, heart rate (HR), and FBF, adequate systemic and ocular circulation was maintained by infusion of a mixture of norepinephrine (NE) and epinephrine (Epi). For evaluation of the validity of our methodology in FBF measurement in rat eye, we determined the relationships between blood pressure or intraocular pressure (IOP) and FBF.
Materials and Methods

Preparation of animals
The present study was conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals adopted by the Committee on the Care and Use of Laboratory Animals of Kitasato University. Male Wistar rats (8 -10 weeks of age) were maintained in a room with constant temperature (22 ± 2°C), constant humidity (55 ± 5%), 12-h light / dark cycles, and with free access to regular rat chow and tap water.
The rats were anesthetized with diethyl ether. After disappearance of the corneal reflex, each animal was placed on a heating pad. A tracheotomy was performed for artificial ventilation. Catheters were inserted into the right jugular vein and both femoral veins for administration of drugs. The left femoral artery was cannulated for measurement of arterial pressure (AP), which was recorded on a thermal pen recorder (WT-645G; Nihon Kohden, Tokyo), via a pressure transducer (DX-360, Nihon Kohden) and a preamplifier (AP-610G, Nihon Kohden). In the rats used in the blood withdrawal study, the other femoral artery was additionally cannulated for blood withdrawal. HR was measured with a cardiotachometer (AT-601G, Nihon Kohden) triggered by the blood pressure pulse. AP and HR were digitized at 1 Hz (SCIENCE LINK II; Keisoku Giken, Utsunomiya) and stored on the hard disk of a dedicated laboratory computer system (PowerBook 165C; Apple Japan, Tokyo).
Measurement of FBF
We assessed the effects of drugs on the FBF using a laser-Doppler blood-flowmetry (Omega Flow FLO-N1; Omegawave, Tokyo) and a high-resolution laser-Doppler imager (MoorLDI-HR; Moor Instruments, Wilmington, DE, USA). Although these are non-contact type of laser-Doppler flowmeters, hydroxyethyl cellulose (SCOPISOL 15 ® ; Senju Pharmaceutical, Osaka) was dropped onto the cornea to prevent drying of the eye.
Laser-Doppler blood-flowmetry FLO-N1
The non-contact type of probe (outer diameter: 0.5 mm) was placed along the bore scope-type objective lens for small animals (Model 01, magnification ×20; Scalar, Tokyo). We monitored the fundus by using the digital fundus camera (D1 or D1x; Nikon, Tokyo) that was equipped with the objective lens before the experiments in order to confirm the region of the fundus to be illuminated by the laser. Blood flow in the region including the optic nerve head was measured using a laser-Doppler blood-flowmetry (FLO-N1). Blood flow was recorded on an ink-writing recorder (R-62; Rikadenki Kogyo, Tokyo) and was digitized at 1 Hz (SCIENCE LINK II) and stored on the hard disk of the PowerBook 165C computer.
High-resolution laser-Doppler imager MoorLDI-HR
The high-resolution laser-Doppler imager (MoorLDI-HR) sequentially scans the region including the eye and periocular area (1.5 × 1.5 cm) in approximately 2 min and displays a color-coded image representing blood flow distribution. Low or no blood perfusion is displayed as dark blue, and the highest perfusion level is displayed as red colors. The laser-Doppler image data of blood flow were stored on the hard disk of a personal computer and analyzed using the MoorLDI Image Processing software (version 5.0, Moor Instruments).
Protocols
Prevention of movement of the eye was very important for consistent blood flow measurements. Therefore, in the present study, rats were treated with TTX (50 µg / kg, i.v.) under artificial ventilation with room air (stroke volume: 10 mL / kg and frequency: 80 strokes/ min) using a rodent respirator (SN-480-7; Sinano, Tokyo). In the preliminary study, we found that the dose of TTX completely prevented movement of the eye and dilated the pupils for several hours. This procedure also abolished the pressor response to spinal cord stimulation and the acetylcholine-induced reflex tachycardia observed in anesthetized rats for several hours (32) . Thus, a single bolus injection of TTX allowed us to continuously measure a particular region of the fundus for several hours. AP, HR, and FBF were decreased after injection of TTX (Table 1) ; therefore, a mixture solution of NE and Epi (1:9) was continuously injected into the right jugular vein at a constant rate by means of a syringe pump (Harvard Apparatus, South Natick, MA, USA) to maintain these parameters at the normal levels [mean arterial pressure (MAP), 104 ± 2 mmHg; HR, 419 ± 11 beats / min; FBF, 103 ± 3.9%]. The infusion rates of NE and Epi were 0.3 -0.5 and 2.7 -4.5 µg ⋅ kg −1 ⋅ min −1 , respectively. The MAP, HR, and FBF of pre-TTX level were maintained throughout the infusion period.
were injected into both femoral veins. Indomethacin (5 mg / kg, i.v.) was injected to exclude the influence of endogenous PGs.
To validate our methodology for measuring FBF, two sets of experiments were performed. In the first set of experiments, we examined how changes in blood pressure alter FBF. Change in blood pressure was induced by a stepwise cumulative blood withdrawal of 2 mL/ kg of body weight from the right femoral artery. In the second set of experiments, we determined how IOP affects FBF. The anterior chamber of the eye was cannulated from the cornea with a 27-gauge needle connected to a bottle containing saline. IOP was increased by elevating the saline bottle in a stepwise manner.
Drugs
The following drugs were used: 8-(4-chlorophenylthio)-cAMP (8-cpt-cAMP) sodium salt, (−) epinephrine (+) bitartrate, indomethacin, nicardipine hydrochloride, N G -nitro-L-arginine methyl ester, (−)-norepinephrine bitartrate (Sigma, St. Louis, MO, USA); tetrodotoxin (TTX; Wako Pure Chemical, Osaka); PGE 1 , PGE 2 , and PGI 2 (Cayman Chemical, Ann Arbor, MI, USA). Norepinephrine (NE) and epinephrine (Epi) were dissolved in saline containing 0.01% L-ascorbic acid. Indomethacin was dissolved in 0.24% Na 2 CO 3 solution. Nicardipine was dissolved in vehicle (polyethylene glycol : ethanol : distilled water = 3:1:1) and further diluted in saline. PGE 1 and PGE 2 were dissolved in ethanol and then diluted in PBS (−) or saline. PGI 2 was dissolved in vehicle (0.05 M glycine-NaOH buffer, pH 9.0). TTX and 8-cpt-cAMP were dissolved in saline.
Statistical analyses
Data are presented as means ± S.E.M. The significance of the difference between mean values was evaluated with GraphPad Prism TM (GraphPad Software, Inc., San Diego, CA, USA) by the unpaired t-test with Welch's correction if necessary and repeated measures of ANOVA followed by the Bonferroni correction. A P value smaller than 0.05 was considered to be statistically significant. Figure 1 shows the relationships between MAP or IOP and FBF measured with a laser-Doppler bloodflowmetry (FLO-N1). As blood pressure decreased due to a stepwise blood withdrawal, FBF decreased ( Fig. 1A) . However, the relationship between MAP and FBF was not linear. Figure 1B shows the effect of a stepwise increase in IOP (10 -70 mmHg) on FBF. Smaller changes in IOP (up to 20 mmHg) did not affect FBF, whereas larger changes in IOP (>30 mmHg) reduced FBF. Systolic blood pressure was constant during the stepwise increase in IOP (data not shown).
Results
We first evaluated the effects of vasodilatory drugs on FBF by laser-Doppler blood-flowmetry (FLO-N1). Figure 2 shows changes in FBF and MAP in response to intravenous infusion of PGE 1 (2 -10 µg ⋅ kg −1 ⋅ min −1 ). Infusion of PGE 1 increased FBF in a dose-dependent manner ( Fig. 2A ). MAP was reduced by infusion of (16, 31) . Therefore, we examined whether 8-cpt-cAMP, a cAMP analogue, increases FBF and decreases MAP. As shown in Fig. 5 , like vasodilatory PGs, 8-cpt-cAMP (30 µmol / kg) increased FBF ( Fig. 5A ) and decreased MAP (Fig. 5B ). We also compared the effects of 8-cpt-cAMP on FBF and MAP with those of nicardipine, a Ca 2+ -channel blocker (Fig. 5: A  and B) . Interestingly, 8-cpt-cAMP (30 µmol / kg) and nicardipine (1 µg ⋅ kg −1 ⋅ min −1 ) produced comparable depressor effects (8-cpt cAMP, 24.1 ± 0.9% vs nicardipine, 25.8 ± 1.8%, n = 3 -5); however, 8-cpt cAMP, but not nicardipine, increased FBF (8-cpt cAMP, 11.2 ± 1.7% vs nicardipine, 2.4 ± 3.1%, n = 3 -5). These results suggest that cAMP-elevating agents act more selectively than Ca 2+ -channel blockers on retinal / choroidal blood vessels.
We next evaluated the effects of vasodilatory PGs and nicardipine on FBF using a high-resolution laser-Doppler blood imager (MoorLDI-HR). MoorLDI-HR provides 2D maps of blood flow and the laser-Doppler images could be analyzed using a dedicated software (MoorLDI software version 5.0). Figure 6A illustrates a right frontal view of the rat and a representative color image showing basal blood flow in the area including the eye (1.5 × 1.5 cm). The image took 2 min to collect and comprises 22,500 data points color-coded to represent blood flow in the area. The eye was displayed red, indicating that its blood flow was much higher than that of the periocular region. After the death of the animal, the blood flow signals were almost abolished. The area including the entire fundus, which is outlined in black, was assessed using the MoorLDI software. The area was 0.25 ± 0.03 cm 2 .
The color images show blood flow in an area including the eye before and during infusion of PGE 1 (2 -10 µg ⋅ kg −1 ⋅ min −1 ) ( Fig. 6B, upper) . To display the changes in blood flow more clearly, each image was subtracted by the initial blood flow (before infusion) ( Fig. 6B, lower) . The images clearly indicate that PGE 1 increased FBF in a dose-dependent manner. By comparison, as shown in Fig. 6C , color images of blood flow before and during infusion of nicardipine (0.3 -3 µg ⋅ kg −1 ⋅ min −1 ) indicate that the drug decreased FBF in a dose-dependent manner. Figure 7 shows the changes in FBF measured with the MoorLDI-HR. Mean values of FBF were obtained from analysis of the color laser-Doppler images using the MoorLDI software. PGE 1 (2 -10 µg ⋅ kg −1 ⋅ min −1 ) caused a dose-dependent increase in FBF (Fig. 7A) , whereas nicardipine (0.3 -3 µg ⋅ kg −1 ⋅ min −1 ) showed a slight, but not significant, decrease in FBF (Fig. 7B) respectively. These results were consistent with those obtained from experiments by laser-Doppler bloodflowmetry (FLO-N1).
Discussion
An understanding of the physiological regulation of hemodynamics in the eye is important because abnormal retinal / choroidal hemodynamics can manifest in the ocular diseases such as diabetic retinopathy, and glaucoma; and they may be associated with an increased risk for development of these diseases. In the present study, we established an experimental system for assessing blood flow in rat fundus and found that intravenously administered PGE 1 , PGE 2 , and PGI 2 increase FBF even when they cause a significant depressor response in rats. Furthermore, we demonstrate that 8-cpt-cAMP, a cAMP analogue, increased FBF and decreased blood pressure similar to the pattern of vasodilatory PGs, whereas nicardipine, a Ca 2+ -channel blocker, failed to increase FBF despite its depressor effect. These results suggest that vasodilatory PGs increase FBF through the elevation of cAMP and exhibit the potent relaxant effect on blood vessels in retinal / choroidal circulation.
Most research in the field of ocular circulation has been conducted using larger animals, which due to their size, can easily be handled. These studies have increased our knowledge about the physiology of ocular circulation. However, to further facilitate investigations on the regulatory mechanism(s) of ocular circulation, a sophisticated experimental system to assess the ocular hemodynamics for small animals should be developed. In addition, an accurate evaluation of effects of vasoactive factors and cytokines on retinal / ocular vessels in vivo is also necessary. In the present study, we treated rats with TTX because the treatment completely prevented the movement of the eye and enabled us to consistently measure FBF for several hours. TTX not only dilates the pupil but also eliminates neuronal influences, including neuronal reflex. Therefore, pharmacological interventions to dilate the pupil and remove the neuronal reflex are not required under treatment with TTX. Although one problem is an alteration of hemodynamics after TTX treatment, the lowered blood pressure, HR, and FBF can be counteracted by infusion of a mixture of NE and Epi.
In the present study, we evaluated changes in FBF evoked by the drugs administered systemically. Despite their depressor effects, all drugs tested did not affect HR because of the elimination of neuronal reflex by treatment with TTX. Therefore, it appears that increase in FBF and decrease in AP result from dilation of blood vessels in retina and choroid and dilatation of those in peripheral resistance vessels, respectively. However, the vasodilatory effects of the drugs on retinal and choroidal blood vessels might be underestimated because hemodynamic changes induced by systemic administration of the drugs affect the ocular hemodynamics. In fact, we found that decreases in blood pressure due to a stepwise blood withdrawal reduced FBF. Nevertheless, our present study indicate that even when the drugs, which have the potent relaxing action on retinal / choroidal blood vessels, are administrated intravenously, we can detect their vasodilatory effects on the vessels as increases in FBF. Our approach may be a simple evaluation and screening method for the potent vasodilators of retinal / choroidal blood vessels.
Alternative routes for drug administration are intraarterially injection and topical administration as eyedrops. The intra-arterially administration appears to be preferable, when the effects of agents that are metabolized by enzymes present in the blood and the liver and are trapped by lungs are evaluated. On the other hand, the administration of eyedrops is a routine method for drug application in the clinical usage. Further studies are required to evaluate the effects of vasodilatory PGs administered through routes other than intravenous administration. PGE 1 and PGE 2 exert their effects through activation of EP receptors, which are classified into four subtypes (EP 1 -EP 4 ). Among EP receptors, EP 2 and EP 4 receptors couple to Gs proteins and stimulation of the receptors leads to a relaxation of vascular smooth muscle through the elevation of intracellular cAMP (16) . Therefore, it is likely that PGE 1 and PGE 2 increase FBF and decrease AP through stimulation of EP 2 and / or EP 4 receptors. On the other hand, actions of PGI 2 seem to be mediated by increased cAMP due to stimulation of IP receptors, which couple to Gs proteins (16) . Our results strongly suggest the presence of EP 2 and / or EP 4 receptors and IP receptors on the blood vessels in retina and choroid, in addition to the peripheral resistance vessels, in rats. Thus, the vasodilatory PGs-cAMP pathway could play a role in the control of rat retinal and choroidal circulation as a vasodilatory regulator.
Studies demonstrated that nicardipine, a Ca 2+ -channel blocker, could improve the impaired cerebral circulation (33, 34) . The ocular vasculature anatomically and functionally resembles the cerebral vasculature. For example, 1) the ophthalmic artery that branches into the retinal artery and posterior ciliary arteries are diverged from the internal carotid artery, 2) retinal endothelial cells form the blood-retinal barrier which functions similarly to the blood-brain barrier (35, 36) , and 3) as cerebral circulation, autoregulatory mechanism for blood flow is present in the retinal and optic nerve head circulation (36, 37) . Therefore, we hypothesized that nicardipine might increase FBF. However, the present study showed that infusion of nicardipine had a tendency to decrease FBF, rather than increase it, although it produced a comparable depressor response with vasodilatory PGs and 8-cpt-cAMP. These results suggest that vasodilatory PGs and cAMP act more selectively than Ca 2+ -channel blockers on retinal / chroidal blood vessels. Because the decreases in systemic blood pressure can reduce FBF, nicardipine might fail to increase FBF. Since several studies demonstrated that Ca 2+channel blockers, including nicardipine, increased optic nerve head blood flow in cats and rabbits (38 -40) , the effects of Ca 2+ -channel blockers may be dependent on animal species.
In the present study, blood flow in the rat fundus was assessed using two non-invasive type of laser-Doppler blood flowmeters, one is the laser-Doppler flowmeter (FLO-N1) and the other is the laser-Doppler color imager (MoorLDI-HR). In both devices, the technical principle for blood flow measurement is based on the Doppler effect wherein the light scattered by moving red blood cell, according to the theory of Bonner and Nossal (41 -43) . However, FLO-N1 allows local and continuous recording of blood flow in the region of fundus to be illuminated by the laser, whereas MoorLDI-HR, which is a laser-Doppler flowmetry with a scanning laser system, allows visualization of blood flow in the entire fundus and quantification of the averaged blood flow. Because of the heterogeneity of vessel distribution in the fundus and the regional variations in blood flow, changes in blood flow in the area measured by FLO-N1 may fail to represent changes in blood flow of the entire fundus. On the other hand, because MoorLDI-HR requires two minutes to move the probe to obtain sufficient data points to represent the entire fundus, it may fail to detect dynamic blood flow change. In the present study, results obtained from experiments using FLO-N1 are almost the same as those with MoorLDI-HR. These suggest that changes in blood flow in the area measured with FLO-N1 represent changes in blood flow of the entire fundus. Moreover, MoorLDI-HR showed a sufficient sensitivity to detect changes in blood flow when drugs were infused continuously.
In FLO-N1 and MoorLDI-HR, the laser light penetrates the tissue to a depth of approximately 1 mm. Therefore, these devices should measure blood flows in retinal and choroidal circulation. Indeed, changes in FBF induced by a stepwise hypotension and the relationship between IOP and FBF indicate the existence of an autoregulatory mechanism for FBF measured by the flowmeter. Because the autoregulatory mechanism plays an important role in the regulation of retinal hemodynamics, the results suggest the contribution of retinal blood flow to the FBF we measured. If simultaneous determination of FBF and responsiveness of retinal blood vessels to vasoactive agents for small animals were available, the method would be a more powerful tool to understand the ocular circulation. Now we are conducting experiments to establish a procedure to simultaneously determine FBF and measure diameters of retinal arterioles and venules. Impairment of retinal and choroidal circulation contributes to the pathogenesis of diabetic retinopathy (1, 2) and glaucoma (3, 4) . Therefore, improvement of the impaired retinal / choroidal circulation would be one of the strategies of drug therapy for such ocular diseases. According to this concept, vasodilatory PGs such as PGE 1 , PGE 2 , and PGI 2 should become candidates of therapeutics to prevent the development of ocular diseases, which are associated with impaired retinal Fig. 7 . Changes in fundus blood flow (FBF) in response to infusion of PGE1 (2 -10 µg ⋅ kg −1 ⋅ min −1 ) (A) and nicardipine (0.3 -3 µg ⋅ kg −1 ⋅ min −1 ) (B) assessed using MoorLDI software. PGE1 significantly increased FBF, but nicardipine dosedependently decreased FBF. Data are expressed as percentages of the control levels (before infusion). The peak values for each dose are shown. Each column with a vertical bar represents the mean ± S.E.M. of three animals. *P<0.05 vs corresponding control values (before infusion).
/ choroidal circulation. These hypotheses must be tested in future studies.
In summary, we found that vasodilatory PGs (PGE 1 , PGE 2 , and PGI 2 ) and 8-cpt cAMP, but not nicardipine, increase FBF by using laser-Doppler blood-flowmetry (FLO-N1) and the high-resolution laser-Doppler imager (MoorLDI-HR) despite their depressor effects in rats. Thus, in addition to laser-Doppler flowmeter, laser-Doppler perfusion imaging is a promising tool for noninvasive measurement of the FBF of rats. The experimental system established in the present study would be useful for better understanding of the regulatory mechanisms for rat FBF and provide us opportunities to evaluate effects of drug treatment on the impaired retinal / choroidal circulation.
